Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophagus Cancer, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Not applicableNot Yet RecruitingNCT07533357
What this trial is testing

Tpex Subsets in Negative Tumor Draining Lymph Nodes for Predicting the Efficacy of PD 1 Inhibitors in Advanced or Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Fudan University 158
Testing effectiveness (Phase 2)Study completedNCT01129206
What this trial is testing

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinomas of the Gastroesophageal JunctionRecurrent Esophageal Cancer+2 more
Ohio State University Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00971841
What this trial is testing

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer

Who this might be right for
Esophageal Cancer
Bristol-Myers Squibb 1
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00004127
What this trial is testing

Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
University of Chicago 35
Early research (Phase 1)Not Yet RecruitingNCT07154108
What this trial is testing

Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer

Who this might be right for
Esophageal CancerHead and Neck Cancer (H&Amp;Amp;Amp;N)
Sichuan University 40
Not applicableStudy completedNCT00003321
What this trial is testing

Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 370
Testing effectiveness (Phase 2)Study completedNCT00702884
What this trial is testing

Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Tony Bekaii-Saab 25
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT00017212
What this trial is testing

DX-8951f in Treating Patients With Metastatic Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06603987
What this trial is testing

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Who this might be right for
Thoracic Solid Malignant Tumor
Stella Pharma Corporation 30
Not applicableUnknownNCT05056051
What this trial is testing

Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus

Who this might be right for
Barrett EsophagusEsophageal Cancer
Northwestern University 200
Not applicableUnknownNCT05349045
What this trial is testing

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
The First Affiliated Hospital of Zhengzhou University 300
Testing effectiveness (Phase 2)UnknownNCT05866510
What this trial is testing

Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Peking University 47
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT02350517
What this trial is testing

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yuhong Li 52
Testing effectiveness (Phase 2)UnknownNCT03011255
What this trial is testing

Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsEsophageal DiseasesDigestive System Diseases
Shixiu Wu 20
Testing effectiveness (Phase 2)UnknownNCT00003326
What this trial is testing

Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Theradex 100
Testing effectiveness (Phase 2)Study completedNCT00381706
What this trial is testing

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 245
Next Page